Turning Point Therapeutics
Why Robinhood?
You can watch TPTX and buy or sell other stocks, ETFs, and their options commission-free!About TPTX
Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor.
TPTX Key Statistics
Stock Snapshot
The current Turning Point Therapeutics(TPTX) stock price is $76.01, with a market capitalization of 3.78B. The stock trades at a price-to-earnings (P/E) ratio of -11.01.
On 2026-05-02, Turning Point Therapeutics(TPTX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Turning Point Therapeutics(TPTX) stock has reached 0, versus its average volume of 1.17M.
The stock's 52-week range extends from a low of $23.77 to a high of $82.20.
The stock's 52-week range extends from a low of $23.77 to a high of $82.20.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.